Exploring the interactions between the human and viral genomes.


Journal

Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 29 08 2019
accepted: 31 10 2019
pubmed: 16 11 2019
medline: 13 6 2020
entrez: 16 11 2019
Statut: ppublish

Résumé

Over the last decade, genome-wide association studies led to major advances in identifying human genetic variants associated with infectious disease susceptibility. On the pathogen side, comparable methods are now applied to identify disease-modulating pathogen variants. As host and pathogen variants jointly determine disease outcomes, the most recent development has been to explore simultaneously host and pathogen genomes, through so-called genome-to-genome studies. In this review, we provide some background on the development of genome-to-genome analysis and we detail the first wave of studies in this emerging field, which focused on patients chronically infected with HIV and hepatitis C virus. We also discuss the need for novel statistical methods to better tackle the issues of population stratification and multiple testing. Finally, we speculate on future research areas where genome-to-genome analysis may prove to be particularly effective.

Identifiants

pubmed: 31729546
doi: 10.1007/s00439-019-02089-3
pii: 10.1007/s00439-019-02089-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

777-781

Auteurs

Jacques Fellay (J)

School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. jacques.fellay@epfl.ch.
Precision Medicine Unit, University Hospital and University of Lausanne, Lausanne, Switzerland. jacques.fellay@epfl.ch.
Swiss Institute of Bioinformatics, Lausanne, Switzerland. jacques.fellay@epfl.ch.

Vincent Pedergnana (V)

French National Center for Scientific Research (CNRS), Laboratory MIVEGEC (CNRS, IRD, UM), Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH